Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 103

Sort by

Sort Order Select

Journal Articles

A “Goldilocks” approach to CNS leukemia is needed

Christina Halsey, Gabriele Escherich

Blood (2021) 138 (4): 288–289.

https://doi.org/10.1182/blood.2021011461

Published: 2021

Journal Articles

Precision Medicine Treatment in Older AML: Results of Beat AML Master Trial

Blood (2019) 134 (Supplement_1): 175.

https://doi.org/10.1182/blood-2019-130201

Published: 2019

Journal Articles

A Phase 1 Dose Escalation Study of Milademetan in Combination with 5-Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Courtney D. DiNardo, MDMSc, Rebecca Olin, MDMS, Jo Ishizawa, MD PhD, Hiroyuki Sumi, PhD, Jingdong Xie, PhD, Kazunobu Kato, MD PhD, Prasanna Kumar, PhD, Michael Andreeff, MD PhD

Blood (2019) 134 (Supplement_1): 3932.

https://doi.org/10.1182/blood-2019-122241

Published: 2019

Journal Articles

Humanized CD19-Specific Chimeric Antigen Receptor T Cells for Acute Lymphoblastic Leukemia

Jiang Cao, MD, Hai Cheng, MD, Kunming Qi, Wei Chen, Ming Shi, Junnian Zheng, Kailin Xu, MD

Blood (2019) 134 (Supplement_1): 3872.

https://doi.org/10.1182/blood-2019-128286

Published: 2019

Journal Articles

Encouraging Results with ALL IC-BFM 2009 Protocol Therapy in Pediatric Acute Lymphoblastic Leukemia/Lymphoma in Resource-Limited Setting: A Single-Center Study from India

Uttam Kumar Nath, MDDM, Debranjani Chattopadhyay, MD, Anamika Bakliwal, MD, Sudeep Vaniyath, MD, Rituparna Chetia, MD, Ashok K Rajoreya, MD

Blood (2019) 134 (Supplement_1): 5118.

https://doi.org/10.1182/blood-2019-127985

Published: 2019

Journal Articles

A Case of Acute Lymphocytic Leukaemia with t(3;13) and Central Nervous System Leukemia after Allogenic Cord Blood Transplantation

Yaqun Hong, Xiaofan Li, MD PhD, Huang Jiafu, Zhenshu Xu, MD, Nainong Li, MD PhD

Blood (2019) 134 (Supplement_1): 5199.

https://doi.org/10.1182/blood-2019-130402

Published: 2019

Journal Articles

Clinical Characteristics and Outcome of Biphenotypic Acute Leukemia: 10 Cases Report and Literature Review

Jifeng Yu, MD, Yingmei Li, MD, Haizhou Xing, Hui Sun, Dingming Wan, MD, Yanfang Liu, Xinsheng Xie, MD, Chong Wang, Ling Sun, MD PhD, Kai Sun, MD, Zhongxing Jiang, MD PhD

Blood (2019) 134 (Supplement_1): 5207.

https://doi.org/10.1182/blood-2019-127580

Published: 2019

Journal Articles

A Long-Term Retrospective Analysis of Arsenic-Containing Triple-Agents Treatment for Acute Promyelocytic Leukemia (APL) in a Cohort from a Single Hospital

Xian Zhang, PhD, Junfang Yang, MD, Fanyong LV, Gailing Zhang, MD, Yunchao Su, MD, Peihua Lu

Blood (2018) 132 (Supplement 1): 4060.

https://doi.org/10.1182/blood-2018-99-117795

Published: 2018

Journal Articles

Stearoyl-CoA Desaturase (SCD) Enhances Central Nervous System Leukemia

Angela Maria Savino, PhD, Orianne Olivares, PhD, Shani Barel, Lev Yakimov, Ifat Geron, Hila Fishman, Inbal Mor, Ifat Abramovich, Sara Isabel Fernandes, Eyal Gottlieb, Christina Halsey, MD PhD, Shai Izraeli, MD

Blood (2018) 132 (Supplement 1): 389.

https://doi.org/10.1182/blood-2018-99-114749

Published: 2018

Journal Articles

Piggybac CD19 CAR T Cells Eradicate CNS Leukemia By Direct Delivery into Cerebral Ventricle of Xenograft Mice Model

Kuniaki Tanaka, MD, Itaru Kato, MD, PhD, Miyuki Tanaka, MD, PhD, Daisuke Morita, MD, PhD, Yoshiyuki Takahashi, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Katsutsugu Umeda, MD, PhD, Hidefumi Hiramatsu, MD, PhD, Souichi Adachi, MD PhD, Junko Takita, MD, PhD, Yozo Nakazawa, MD, PhD

Blood (2018) 132 (Supplement 1): 4028.

https://doi.org/10.1182/blood-2018-99-111733

Published: 2018

Journal Articles

Effective Chimeric Antigen Receptor T Cell Therapy for Relapsed and Refractory Acute Lymphoblastic Leukemia in Children Can be Administered Safely Under the Real-Time Monitoring of Th1/Th2 Cytokine Patterns Measured By the Cytometric Bead Array Technology

Yongmin Tang, MD, Diying Shen, MD, Lei Xiao, PhD, Hua Song, MD, Fenying Zhao, MD, Xiaojun Xu, MD, Weiqun Xu, MD PhD, Di Wang, MD, Juan Liang, MD, Meixin Fang, MD, Chan Liao, MD PhD, Sisi Li, MD PhD, Ning Zhao, MS, Wei Huang, MS

Blood (2018) 132 (Supplement 1): 4030.

https://doi.org/10.1182/blood-2018-99-120007

Published: 2018

Journal Articles

Overcoming Acute Lymphoblastic Leukemia Chemoresistance Induced By the Meninges

Maryam Ebadi, MD, Leslie M. Jonart, MS, Patrick Basile, MD, Jessica Makori, Peter M. Gordon, MD PhD

Blood (2018) 132 (Supplement 1): 2653.

https://doi.org/10.1182/blood-2018-99-115671

Published: 2018

Journal Articles

Clinical Significance of Novel SH2B3 Mutations in Adult Chinese Acute Lymphoblastic Leukemia Patients

Yan Gu, MD, Qi Han, MD, Mary McGrath, Soumya Iyer, Chunhua Song, MD PhD, Zheng Ge, MD PhD

Blood (2018) 132 (Supplement 1): 2657.

https://doi.org/10.1182/blood-2018-99-110793

Published: 2018

Journal Articles

Influence of the CNS Niche on Acute Lymphoblastic Leukemia Biology

Patrick Basile, MD, Peter M. Gordon, MD PhD, Leslie M. Jonart, MS, Maryam Ebadi, MD, Kim Johnson, Jessica Makori

Blood (2018) 132 (Supplement 1): 4084.

https://doi.org/10.1182/blood-2018-99-116777

Published: 2018

Journal Articles

Central Nervous System Involvement Detected By Flow Cytometry Is a Risk Factor for Relapse in Childhood Acute Lymphoblastic Leukemia

Maria Thastrup, PhD, Hanne Vibeke Marquart, MD PhD, Mette Levinsen, PhD, Kathrine Grell, PhD, Jonas Abrahamsson, Birgitte Klug Albertsen, MD, Thomas Leth Frandsen, MD PhD, Arja Harila-Saari, MD Associate professor, Päivi Maria Lähteenmäki, MD PhD, Riitta Niinimäki, MD, Cornelis Jan Pronk, MD PhD, Aina Ulvmoen, PhD, Goda Vaitkeviciene, MD, Mervi Taskinen, MD PhD, Kjeld Schmiegelow, MD DMSc

Blood (2018) 132 (Supplement 1): 657.

https://doi.org/10.1182/blood-2018-99-114173

Published: 2018

Journal Articles

Initial Report of the Beat AML Umbrella Study for Previously Untreated AML: Evidence of Feasibility and Early Success in Molecularly Driven Phase 1 and 2 Studies

Blood (2018) 132 (Supplement 1): 559.

https://doi.org/10.1182/blood-2018-99-118494

Published: 2018

Journal Articles

Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse

Xian Zhang, PhD, Xin-an Lu, Junfang Yang, MD, Fanyong LV, Min Xiong, Jianping Zhang, Xiaosu Zhou, Ting He, Peihua Lu

Blood (2018) 132 (Supplement 1): 280.

https://doi.org/10.1182/blood-2018-99-115642

Published: 2018

Journal Articles

Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High Risk B-Lymphoblastic Leukemia: Results of Children's Oncology Group Study AALL1131

Wanda L. Salzer, MD, Michael J. Burke, MD, Meenakshi Devidas, PhD, Lia Gore, MD, Joanne M. Hilden, MD, Eric Larsen, MD, Karen R. Rabin, MD PhD, Patrick A. Zweidler-McKay, MD PhD, Michael J. Borowitz, MD PhD, Brent Wood, MD PhD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Naomi Winick, MD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD

Blood (2018) 132 (Supplement 1): 35.

https://doi.org/10.1182/blood-2018-99-116180

Published: 2018

Journal Articles

The Meninges Enhance Acute Lymphoblastic Leukemia Chemoresistance in the Central Nervous System

Maryam Ebadi, MD, Leslie M. Jonart, MS, Jordan Naumann, MS, Peter M. Gordon, MDPhD

Blood (2017) 130 (Supplement 1): 1257.

https://doi.org/10.1182/blood.V130.Suppl_1.1257.1257

Published: 2017

Journal Articles

Treatment Outcome of Dasatinib in Combination with Less-Intensive Induction, Homobarringtonie, Cytarabine, G-SCF in Newly Diagnosed Patients with Ph+ALL

Stephen Yang Liang, MD

Blood (2017) 130 (Supplement 1): 3882.

https://doi.org/10.1182/blood.V130.Suppl_1.3882.3882

Published: 2017

NARROW

A “Goldilocks” approach to CNS leukemia is needed

Precision Medicine Treatment in Older AML: Results of Beat AML Master Trial

A Phase 1 Dose Escalation Study of Milademetan in Combination with 5-Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Humanized CD19-Specific Chimeric Antigen Receptor T Cells for Acute Lymphoblastic Leukemia

Encouraging Results with ALL IC-BFM 2009 Protocol Therapy in Pediatric Acute Lymphoblastic Leukemia/Lymphoma in Resource-Limited Setting: A Single-Center Study from India

A Case of Acute Lymphocytic Leukaemia with t(3;13) and Central Nervous System Leukemia after Allogenic Cord Blood Transplantation

Clinical Characteristics and Outcome of Biphenotypic Acute Leukemia: 10 Cases Report and Literature Review

A Long-Term Retrospective Analysis of Arsenic-Containing Triple-Agents Treatment for Acute Promyelocytic Leukemia (APL) in a Cohort from a Single Hospital

Stearoyl-CoA Desaturase (SCD) Enhances Central Nervous System Leukemia

Piggybac CD19 CAR T Cells Eradicate CNS Leukemia By Direct Delivery into Cerebral Ventricle of Xenograft Mice Model

Effective Chimeric Antigen Receptor T Cell Therapy for Relapsed and Refractory Acute Lymphoblastic Leukemia in Children Can be Administered Safely Under the Real-Time Monitoring of Th1/Th2 Cytokine Patterns Measured By the Cytometric Bead Array Technology

Overcoming Acute Lymphoblastic Leukemia Chemoresistance Induced By the Meninges

Clinical Significance of Novel SH2B3 Mutations in Adult Chinese Acute Lymphoblastic Leukemia Patients

Influence of the CNS Niche on Acute Lymphoblastic Leukemia Biology

Central Nervous System Involvement Detected By Flow Cytometry Is a Risk Factor for Relapse in Childhood Acute Lymphoblastic Leukemia

Initial Report of the Beat AML Umbrella Study for Previously Untreated AML: Evidence of Feasibility and Early Success in Molecularly Driven Phase 1 and 2 Studies

Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse

Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High Risk B-Lymphoblastic Leukemia: Results of Children's Oncology Group Study AALL1131

The Meninges Enhance Acute Lymphoblastic Leukemia Chemoresistance in the Central Nervous System

Treatment Outcome of Dasatinib in Combination with Less-Intensive Induction, Homobarringtonie, Cytarabine, G-SCF in Newly Diagnosed Patients with Ph+ALL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only